According to IMARC Group’s latest report, titled “Virtual Clinical Trials Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, The global virtual clinical trials market grew at a CAGR of around 7% during 2015-2020. Virtual clinical trials (VCT) refer to the clinical tests that are conducted remotely using advanced technological solutions. These virtual trials involve the use of smartphone applications and electronic monitoring devices to diagnose, detect and prevent diseases, along with several web-based platforms to recruit, counsel, measure endpoints and obtain data from the subjects. They also help in generating data regarding the efficiency, effectiveness, and safety of drugs and medical procedures. Compared to the traditional clinical trials, VCTs are less time-consuming, ensure real-time data acquisition and are not affected by delays in patient recruitment as they can be conducted at-home or at remote locations.
Request for a PDF sample of this report: https://www.imarcgroup.com/virtual-clinical-trials-market/requestsample
The rising digitization of the healthcare infrastructures is primarily driving the growth of the market. Besides this, as coronavirus disease continues to spread across the world, there has been a considerable increase in the demand for virtual and remote testing solutions for safe and effective data collection. Furthermore, numerous technological innovations, such as the introduction of virtual patient interaction platforms and the utilization of wearable devices, are acting as other growth-inducing factors. These technologies assist in connecting patients with treating physicians through telemedicine platforms and obtaining e-consent for the trials, thus strengthening the market growth. Additionally, the growing adoption of cloud-based, web-hosted and open-source licensing delivery models is anticipated to further propel the market in the coming years. Looking forward, IMARC Group expects the global virtual clinical trials market to exhibit moderate growth during the next five years.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Competitive Landscape with Key Players:
- Clinical Ink Inc.
- Covance Inc.
- ICON Plc, IQVIA Inc.
- LEO Innovation Lab
- Medable Inc.
- Medidata Solutions Inc. (Dassault Systèmes SE)
- Medpace Holdings Inc.
- Oracle Corporation
- Parexel International Corporation
- PRA Health Sciences
- Signant Health.
Breakup by Study Design:
- Expanded Access
Breakup by Indication:
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/virtual-clinical-trials-market
We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Market Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, and nanotechnology industries. We also provide cost model and manufacturing setup project reports through Syndicated Analytics, a subsidiary of IMARC Group.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800